Kelly 2020.

Methods	Study design: retrospective cohort study  Type of publication: abstract  Setting and dates: specialist palliative care, no dates  Country: Ireland  Language: English Inclusion/exclusion criteria: patients with COVID‐19 referred to specialist palliative care
Participants	Age: median (range): N/A Gender: N/A Ethnicity: N/A Number of participants (recruited/allocated/evaluated): 3 Symptoms at baseline: agitation and dyspnea  Comorbidities: N/A
Interventions	Pharmacological interventions: mean of 28 mg morphine sulphate subcutaneous (s/c), as‐required (range 12.5 to 42.5 mg) for management of dyspnea, and a mean of 28 mg midazolam s/c, as‐required (range 12.5 to 55 mg) for agitation Non‐pharmacological interventions: none
Outcomes	Primary outcomes N/A Secondary outcomes N/A
Notes	Full data not yet published.